Skip to content
Recall Observatory FDA recall evidence

Drug product

GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21

D-1276-2019

April 08, 2019

Class II

Product summary

Firm
American Health Packaging
Event
Event 82593
Status
Terminated
Classification
Class II
Quantity
2,203 cartons (cartons of 30 individual unit doses)
Official record key
drug-enforcement:D-1276-2019

Official wording

Reason: Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.

Code information: Lot # 181288, EXP 5/31/2020

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications